Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bespoke Extracts, Inc. (BSPK)
USD0.13
+0.00 (+3.91%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
2590 Walnut Street 80205
Aurora, CO, US
Aurora, CO, US
CEO
Michael R. Feinsod
Website
bespokeextracts.com
IPO
2008-02-04
CIK 1409197 ISIN US08634Q2084
Description
Bespoke Extracts, Inc. offers a range of cannabidiol (CBD) products sourced from hemp. Their diverse inventory includes various CBD formulations, such as those infused with manuka honey, as well as lotions and balms. Additionally, the company provides CBD extracts available in capsule form, topical applications, and edible gummies. These items are sold directly to consumers through their dedicated e-commerce website, bespokeextracts.com. The business, which changed its name from DiMi Telematics International, Inc. to Bespoke Extracts, Inc. in March 2017, is headquartered in Denver, Colorado.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.13
+0.00 (+3.91%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1.5K
Beta
0.04
Float Shares
6.72M
Free Float %
59.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -34.62% | -13.13% | -42.98% | -48.39% | +0.15% | -34.85% | +13.30% | +50.29% | +957,447.22% | +87,270.05% | -80.45% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.13
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-136.12
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+32,698.7% ★ Q3'25: +148.6% (vs Q2'23)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+78.1% ★ Q3'25: +84.9% (vs Q2'23)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-50.2% Q3'25: -4.2% (vs Q2'23)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-87.5% Q3'25: -11.5% (vs Q2'23)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q3'25: +19.3% (vs Q2'23)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+12.4% Q3'25: +10.6% (vs Q2'23)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-1.66× Q3'25: -9.29× (vs Q2'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
629.7K
OE per share TTM
0.06
Owner's Yield
42.95%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
64.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
10
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Danil Pollack | 119.00M | 51.90% | 119.00M | — | 119.00M | — | IN | — | 2020-12-04 | ↗ |
| 2 | Pollack | 100.00M | 47.50% | 100.00M | — | — | 10.00 | IN | OR PLACE OF ORGANIZATION | 2020-04-30 | ↗ |
| 3 | Management, LLC | 50.00M | 20.10% | 50.00M | — | — | — | IN | — | 2021-11-29 | ↗ |
| 4 | Hunter Garth | 22.50M | 7.10% | 22.50M | — | — | — | IN | — | 2021-12-16 | ↗ |
| 5 | Marc Yahr | 20.00M | 46.59% | 20.00M | — | 20.00M | 10.00 | IN | OR PLACE OF ORGANIZATION | 2017-06-01 | ↗ |
| 6 | Holdings, | 14.56M | 19.85% | — | 14.56M | — | 10.00 | PN | Texas | 2019-06-26 | ↗ |
| 7 | Trading, | 14.56M | 19.85% | — | 14.56M | — | 10.00 | HC | Texas | 2019-06-26 | ↗ |
| 8 | Niquana Noel | 10.00M | 4.40% | 10.00M | — | — | — | IN | — | 2020-12-30 | ↗ |
| 9 | Roberto Fata | 410.0K | 14.03% | 410.0K | — | 410.0K | 10.00 | IN | OR PLACE OF ORGANIZATION | 2017-01-26 | ↗ |
| 10 | Barry Tenzer | 394.0K | 13.48% | 394.0K | — | 394.0K | 10.00 | IN | OR PLACE OF ORGANIZATION | 2017-01-25 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
16.5K
Shares disposed
—
Cash buys
5.00
Cash sales
—
Net activity
+16,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | FEINSOD MICHAEL | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-30 | Garth Tyler Hunter | Director / Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 1,000,000 | D | ↗ |
| 2025-09-11 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 0.27 | 405.00 | 2,512,112 | D | ↗ |
| 2025-09-10 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 0.19 | 380.00 | 2,510,612 | D | ↗ |
| 2025-09-08 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.19 | 475.00 | 2,508,612 | D | ↗ |
| 2025-09-05 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.20 | 500.00 | 2,506,112 | D | ↗ |
| 2025-07-02 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 8,000 | 0.11 | 880.00 | 2,503,412 | D | ↗ |
| 2025-05-12 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.10 | 100.00 | 2,494,612 | D | ↗ |
| 2025-05-09 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.11 | 110.00 | 2,493,612 | D | ↗ |
| 2025-01-23 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,500 | 0.10 | 350.00 | 2,488,112 | D | ↗ |
| 2025-01-22 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,500 | 0.11 | 495.00 | 2,484,112 | D | ↗ |
| 2025-01-03 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,500 | 0.10 | 450.00 | 2,479,612 | D | ↗ |
| 2025-01-02 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 8,500 | 0.11 | 935.00 | 2,475,112 | D | ↗ |
| 2024-11-14 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 0.19 | 285.00 | 2,466,612 | D | ↗ |
| 2024-11-12 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.16 | 400.00 | 2,465,112 | D | ↗ |
| 2024-09-09 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 500 | 0.13 | 65.00 | 2,460,112 | — | ↗ |
| 2024-09-06 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 0.11 | 165.00 | 2,459,612 | — | ↗ |
| 2024-08-28 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 0.09 | 180.00 | 2,458,112 | — | ↗ |
| 2024-08-27 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.09 | 270.00 | 2,456,112 | — | ↗ |
| 2024-08-15 | Garth Tyler Hunter | Director / Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 800,000 | — | ↗ |
| 2024-08-15 | FEINSOD MICHAEL | Director / Officer / 10% Owner | A-Award | A | Common Stock | 300,000 | 0.00 | — | 2,453,112 | — | ↗ |
| 2024-08-02 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 0.08 | 120.00 | 2,152,112 | — | ↗ |
| 2024-08-01 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.07 | 175.00 | 2,150,612 | — | ↗ |
| 2024-07-22 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.07 | 210.00 | 2,148,112 | — | ↗ |
| 2024-07-15 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.07 | 210.00 | 2,145,112 | — | ↗ |
| 2024-06-17 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,000 | 0.13 | 520.00 | 2,142,112 | — | ↗ |
| 2024-05-21 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,250 | 0.13 | 162.50 | 2,138,112 | — | ↗ |
| 2024-05-20 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 750 | 0.14 | 105.00 | 2,136,862 | — | ↗ |
| 2024-05-15 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.15 | 450.00 | 2,136,112 | — | ↗ |
| 2024-05-07 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.11 | 330.00 | 2,133,112 | — | ↗ |
| 2024-04-24 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.11 | 550.00 | 2,130,112 | — | ↗ |
| 2024-03-18 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.15 | 750.00 | 2,125,112 | — | ↗ |
| 2024-03-01 | Garth Tyler Hunter | Director / Officer | A-Award | A | Options (Right to Buy) | 30,000 | 0.22 | 6.6K | 30,000 | — | ↗ |
| 2024-03-01 | FEINSOD MICHAEL | Director / Officer / 10% Owner | A-Award | A | Options (Right to Buy) | 15,000 | 0.22 | 3.3K | 15,000 | — | ↗ |
| 2024-01-24 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,000 | 0.10 | 700.00 | 2,120,112 | — | ↗ |
| 2024-01-23 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 13,000 | 0.08 | 1.0K | 2,117,112 | — | ↗ |
| 2024-01-22 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 12,000 | 0.07 | 840.00 | 2,112,612 | — | ↗ |
| 2024-01-18 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 0.07 | 700.00 | 2,102,612 | — | ↗ |
| 2024-01-17 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.04 | 200.00 | 2,092,612 | — | ↗ |
| 2024-01-12 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.04 | 100.00 | 2,082,612 | — | ↗ |
| 2024-01-08 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.04 | 200.00 | 2,080,112 | — | ↗ |
| 2024-01-05 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 0.03 | 300.00 | 2,075,112 | — | ↗ |
| 2023-12-29 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 12,000 | 0.04 | 480.00 | 2,065,112 | — | ↗ |
| 2023-12-22 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 13,000 | 0.04 | 520.00 | 2,053,112 | — | ↗ |
| 2023-12-04 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,000 | 0.09 | 630.00 | 2,040,112 | — | ↗ |
| 2023-10-16 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.20 | 599.70 | 2,033,112 | — | ↗ |
| 2023-08-17 | Garth Tyler Hunter | Director / Officer | A-Award | A | Options (Right to Buy) | 150,000 | 0.20 | 30.0K | 150,000 | — | ↗ |
| 2023-05-01 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 15,000 | 0.14 | 2.1K | 2,030,112 | — | ↗ |
| 2022-06-30 | FEINSOD MICHAEL | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 8,000,000 | 0.01 | 40.0K | 90,680,000 | — | ↗ |
| 2022-04-13 | FEINSOD MICHAEL | Officer | J-Other | D | Common Stock | 12,320,000 | 0.00 | — | 82,680,000 | — | ↗ |
| 2021-12-14 | Garth Tyler Hunter | Director / Officer | A-Award | A | Common Stock | 22,500,000 | 0.00 | — | 22,500,000 | — | ↗ |
| 2021-12-14 | FEINSOD MICHAEL | Director / Officer / 10% Owner | A-Award | A | Common Stock | 45,000,000 | 0.00 | — | 45,000,000 | — | ↗ |
| 2021-11-19 | Garth Tyler Hunter | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-19 | FEINSOD MICHAEL | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 50,000,000 | — | ↗ |
| 2021-10-28 | Pollack Danil | Director / Officer / 10% Owner | S-Sale | D | Series C Preferred Stock | 1 | 0.00 | — | 0 | — | ↗ |
| 2021-01-21 | Pollack Danil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000,000 | 0.05 | 100.0K | 126,000,000 | — | ↗ |
| 2021-01-07 | Pollack Danil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000,000 | 0.02 | 100.0K | 124,000,000 | — | ↗ |
| 2020-12-01 | Pollack Danil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 20,000,000 | 0.01 | 200.0K | 119,000,000 | — | ↗ |
| 2020-11-10 | Pollack Danil | Director / Officer / 10% Owner | J-Other | A | Common Stock | 15,000,000 | 0.01 | 150.0K | 99,000,000 | — | ↗ |
| 2020-08-12 | Pollack Danil | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 21,000,000 | 0.00 | 21.0K | 84,000,000 | — | ↗ |
| 2020-08-05 | Pollack Danil | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 20,000,000 | 0.00 | 20.0K | 63,000,000 | — | ↗ |
| 2020-06-19 | Pollack Danil | Director / Officer / 10% Owner | M-Exempt | D | Right to purchase | 23,000,000 | 0.00 | 23.0K | 57,000,000 | — | ↗ |
| 2020-06-03 | Pollack Danil | Director / Officer / 10% Owner | M-Exempt | D | Right to purchase | 20,000,000 | 0.00 | 20.0K | 80,000,000 | — | ↗ |
| 2020-04-21 | Pollack Danil | Officer / 10% Owner | — | D | Right to purchase | 100,000,000 | 0.00 | 100.0K | 0 | — | ↗ |
| 2020-04-16 | Noel Niquana Monique | Director / 10% Owner | S-Sale | D | Series C Preferred Stock | 1 | 24,000.00 | 24.0K | 0 | — | ↗ |
| 2020-03-25 | Noel Niquana Monique | Director / 10% Owner | J-Other | D | Series B Preferred Stock | 1 | 24,000.00 | 24.0K | 0 | — | ↗ |
| 2019-10-03 | Noel Niquana Monique | Director / Officer / 10% Owner | J-Other | A | Series B Preferred Stock | 1 | 24,000.00 | 24.0K | 1 | — | ↗ |
| 2018-11-07 | Yahr Marc | Director | J-Other | D | Common Stock | 16,000,000 | 0.00 | — | 4,000,000 | — | ↗ |
| 2018-11-05 | Noel Niquana Monique | Officer / 10% Owner | X-InTheMoney | A | Common Stock | 20,000,000 | 0.00 | 2.0K | 20,000,000 | — | ↗ |
| 2018-10-30 | Noel Niquana Monique | Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-06-10 | Yahr Marc | Director / Officer / 10% Owner | X-InTheMoney | A | Common Stock | 20,000,000 | 0.00 | 20.0K | 20,000,000 | — | ↗ |
| 2017-05-31 | Yahr Marc | Director / Officer / 10% Owner | X-InTheMoney | D | Warrant to Purchase Common Stock | 20,000,000 | 0.00 | 20.0K | 0 | — | ↗ |
| 2017-05-22 | Yahr Marc | Director / Officer / 10% Owner | — | D | Warrant to Purchase Common Stock | 20,000,000 | 0.00 | 2.0K | 0 | — | ↗ |
| 2017-03-28 | TENZER BARRY | Director / Officer / 10% Owner | X-InTheMoney | A | Warrant to Purchase Common Stock | 20,000,000 | 0.00 | 2.0K | 0 | — | ↗ |
| 2017-03-14 | TENZER BARRY | Director / Officer / 10% Owner | A-Award | A | Warrant to Purchase Common Stock | 20,000,000 | 0.00 | 2.0K | 20,000,000 | — | ↗ |
| 2015-07-08 | TENZER BARRY | Director / Officer | A-Award | A | Common Stock | 250,000 | 30,000.00 | 7.50B | 394,000 | — | ↗ |
| 2015-07-08 | Fata Roberto | Director / Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 410,000 | — | ↗ |
| 2014-06-13 | Ivankovich Anthony | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 435,003 | — | ↗ |
| 2014-04-09 | McGlothlin Holdings, Ltd. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 662,667 | — | ↗ |
| 2011-11-10 | TENZER BARRY | Director / Officer / 10% Owner | — | D | Common Stock, $.001 par value | 0 | 0.00 | — | 10,800,000 | — | ↗ |
| 2011-11-10 | Hauser Lyle | 10% Owner | — | D | Common Stock, $.001 par value | 0 | 0.00 | — | 60,960,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-488.7K
Shares Outstanding
11.25M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael R. Feinsod | Chief Executive Officer & Executive Chairman | 120.0K | male |
| Tyler Hunter Garth | President & Director | 96.0K | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BSPK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
